是时候再次尝试序贯治疗方案缓解抑郁症（STAR*D）了吗？ - Suppr | 超能文献

Is It Time to Try Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Again?

作者信息

Perlis Roy H, Fava Maurizio

机构信息

Department of Psychiatry, Massachusetts General Hospital, Boston.

Harvard Medical School, Boston, Massachusetts.

出版信息

JAMA Psychiatry. 2022 Apr 1;79(4):281-282. doi: 10.1001/jamapsychiatry.2021.4281.

DOI:10.1001/jamapsychiatry.2021.4281

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Is It Time to Try Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Again?是时候再次尝试序贯治疗方案缓解抑郁症（STAR*D）了吗？

JAMA Psychiatry. 2022 Apr 1;79(4):281-282. doi: 10.1001/jamapsychiatry.2021.4281.

2

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.缓解抑郁症的序贯治疗方案（STAR*D）研究的背景与原理

Psychiatr Clin North Am. 2003 Jun;26(2):457-94, x. doi: 10.1016/s0193-953x(02)00107-7.

3

Sequenced Treatment Alternatives to Relieve Depression (STAR*D): lessons learned.缓解抑郁症的序贯治疗替代方案（STAR*D）：经验教训

J Clin Psychiatry. 2008 Jul;69(7):1184-5. doi: 10.4088/jcp.v69n0719.

4

Changes in depressive symptoms and social functioning in the sequenced treatment alternatives to relieve depression study.缓解抑郁症的序贯治疗方案研究中抑郁症状和社会功能的变化

J Nerv Ment Dis. 2011 Oct;199(10):807-10. doi: 10.1097/NMD.0b013e31822fcbe2.

5

Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1.复制机器学习方法，以预测 STAR*D 和 CAN-BIND-1 中重度抑郁症患者抗抑郁药物治疗效果。

PLoS One. 2021 Jun 28;16(6):e0253023. doi: 10.1371/journal.pone.0253023. eCollection 2021.

6

Limitations in efficacy of antidepressant monotherapy.抗抑郁药单一疗法的疗效局限性。

J Clin Psychiatry. 2007;68 Suppl 10:8-10.

7

The STAR*D study: treating depression in the real world.

Cleve Clin J Med. 2008 Jan;75(1):57-66. doi: 10.3949/ccjm.75.1.57.

8

Navigating the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study: practical outcomes and implications for depression treatment in primary care.探索缓解抑郁症的序贯治疗方案（STAR*D）研究：初级保健中抑郁症治疗的实际结果及启示

Prim Care. 2007 Sep;34(3):505-19, vi. doi: 10.1016/j.pop.2007.05.006.

9

Baseline difference between patients' and clinicians' rated illness severity scores and subsequent outcomes in major depressive disorder: analysis of the sequenced treatment alternatives to relieve depression data.重度抑郁症患者与临床医生评定的疾病严重程度评分之间的基线差异及后续结果：对缓解抑郁症数据的序贯治疗替代方案的分析

J Clin Psychopharmacol. 2014 Jun;34(3):297-302. doi: 10.1097/JCP.0000000000000112.

10

Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant.在抗抑郁药序贯治疗选择缓解抑郁（STAR*D）试验中，抗抑郁药转换后令人痛苦的不良事件：西酞普兰初始治疗期间不良事件对随后使用替代抗抑郁药发生后续不良事件的影响。

Pharmacotherapy. 2012 Mar;32(3):234-43. doi: 10.1002/j.1875-9114.2011.01020.x.

引用本文的文献

1

Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits.全基因组关联研究治疗抵抗性抑郁症：与代谢特征的共同生物学。

Am J Psychiatry. 2024 Jul 1;181(7):608-619. doi: 10.1176/appi.ajp.20230247. Epub 2024 May 15.